UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
13.49
+0.38 (2.90%)
At close: Jun 27, 2025, 4:00 PM
13.69
+0.20 (1.48%)
After-hours: Jun 27, 2025, 7:50 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $621.99 million as of June 27, 2025. Its market cap has increased by 31.53% in one year.
Market Cap
621.99M
Enterprise Value
547.95M
1-Year Change
31.53%
Ranking
Category
Stock Price
$13.49
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $621.99M, an increase of 241.94%. That is a compound annual growth rate of 16.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 622.00M | 38.41% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |